Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a well-recognized biotechnology company, GenScript has a team of approximately 6,165 employees and has served more than 200,000 customers across over 100 countries and regions.
ProBio is the subsidiary of GenScript Biotech Corporation, proactively providing end-to-end CDMO service from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in antibody protein drugs, Cell and Gene Therapy, vaccines, etc., to accelerate drug development for customers, ProBio’s Antibody Drug Discovery (ADD) service & solutions cover monoclonal Ab lead generation using various platforms & technologies (hybridoma, human combo phage display library, single B cell, humanized mice, single domain Ab), lead characterization via various in vitro function assays and in vivo efficacy models, and lead optimization (humanization, PTM removal, affinity maturation, developability assessment & engineering), as well as construction and characterization of Ab based therapeutic modalities (Bispecific Abs, ADCs and CAR-Ts).